Head to Head Review: Microsoft (NASDAQ:MSFT) & OptimizeRx (NASDAQ:OPRX)

OptimizeRx (NASDAQ:OPRXGet Free Report) and Microsoft (NASDAQ:MSFTGet Free Report) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Profitability

This table compares OptimizeRx and Microsoft’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OptimizeRx 0.03% 6.37% 4.46%
Microsoft 39.04% 32.34% 18.49%

Valuation & Earnings

This table compares OptimizeRx and Microsoft”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OptimizeRx $92.13 million 1.70 -$18.66 million N/A N/A
Microsoft $281.72 billion 10.53 $101.83 billion $15.99 24.99

Microsoft has higher revenue and earnings than OptimizeRx.

Institutional and Insider Ownership

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 71.1% of Microsoft shares are owned by institutional investors. 5.6% of OptimizeRx shares are owned by insiders. Comparatively, 0.0% of Microsoft shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for OptimizeRx and Microsoft, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OptimizeRx 1 2 5 0 2.50
Microsoft 0 4 39 2 2.96

OptimizeRx presently has a consensus price target of $20.50, suggesting a potential upside of 144.63%. Microsoft has a consensus price target of $591.95, suggesting a potential upside of 48.14%. Given OptimizeRx’s higher possible upside, equities analysts plainly believe OptimizeRx is more favorable than Microsoft.

Risk & Volatility

OptimizeRx has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, Microsoft has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Summary

Microsoft beats OptimizeRx on 10 of the 14 factors compared between the two stocks.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Microsoft

(Get Free Report)

Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.

Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.